Sr. Compliance Officer at Eli Lilly and Company

Shanghai, Shanghai, China

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Ability to build and continuously improve affiliate risk management environment
  • Experience leading and developing multi "raise-the-bar" projects in Lilly China (e.g., digital and automation solutions development)
  • Capability to conduct risk-based monitoring activities and programs with high integrity
  • Strong cross-functional collaboration skills across different levels
  • Expertise in driving high quality risk assessment
  • Proficiency in executing risk management strategy
  • Skills in conducting risk detection and prevention capabilities

Responsibilities

  • Lead and develop multi raise-the-bar projects in Lilly China (e.g., digital and automation solutions development)
  • Conduct risk-based monitoring activities and programs with high integrity
  • Collaborate cross-functionally across many different levels to drive high quality risk assessment
  • Execute risk management strategy for the affiliate
  • Develop and enhance risk detection and prevention capabilities of the affiliate
  • Report to Associate Director, Ethics and Compliance, leading monitoring and data intelligence

Skills

Key technologies and capabilities for this role

Risk ManagementComplianceRisk AssessmentData IntelligenceMonitoringProject ManagementDigital SolutionsAutomationEthics

Questions & Answers

Common questions about this position

What is the employment type for the Sr. Compliance Officer position?

The position is full time.

Is this Sr. Compliance Officer role remote or office-based?

This information is not specified in the job description.

What skills are required for the Sr. Compliance Officer role?

The role requires skills in building and improving affiliate risk management, leading multi raise-the-bar projects like digital and automation solutions, conducting risk-based monitoring, risk assessment, executing risk management strategy, and risk detection and prevention.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people, puts people first, and values giving best effort to work while supporting philanthropy, volunteerism, and equal opportunities.

Who does the Sr. Compliance Officer report to?

The role reports to the Associate Director, Ethics and Compliance, leading monitoring and data intelligence.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI